Unfortunately, this combination of needing to push products out quickly while keeping costs down is leading many organizations to undervalue functional testing despite escalating complexity.

A retrospective review was conducted of 1,118 clinical cases where electron transport chain (ETC) functional testing and mtDNA (mitochondrial DNA) genome sequencing were performed on muscle samples.

Whether a follow-up strategy that includes routine functional testing improves clinical outcomes among high-risk patients who have undergone percutaneous coronary intervention (PCI) is uncertain.